Skip to main content
Erschienen in: Herz 6/2019

20.05.2019 | Main topic

COPD and heart failure: differential diagnosis and comorbidity

verfasst von: G. Güder, MD, PhD, S. Störk

Erschienen in: Herz | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Heart failure (HF) and chronic obstructive pulmonary disease (COPD) represent the most important differential diagnoses of dyspnea in elderly people. Heart failure is the inability of the heart to pump sufficient amounts of blood through the cardiovascular system. Pump failure is caused by compromised contractility and/or filling of the ventricles leading to forward and backward failure and subsequently to dyspnea. In COPD, the destruction and remodeling processes of the bronchiolar architecture inhibit proper exhalation of air, thereby leading to exhaustion of the thoracic muscles, insufficient oxygen diffusion, and dyspnea. Despite these fundamental differences in the pathophysiology of both disorders, their clinical presentation may be very similar. This renders accurate and timely diagnosis and therapy, especially in patients with coexisting disease, difficult. This clinical review summarizes typical problems in the diagnosis of COPD, HF, and coincident disease, and describes strategies that help avoid misdiagnosis and ineffective treatment.
Literatur
1.
Zurück zum Zitat Agostoni P, Contini M, Cattadori G et al (2007) Lung function with carvedilol and bisoprolol in chronic heart failure: Is beta selectivity relevant? Eur J Heart Fail 9:827–833CrossRefPubMed Agostoni P, Contini M, Cattadori G et al (2007) Lung function with carvedilol and bisoprolol in chronic heart failure: Is beta selectivity relevant? Eur J Heart Fail 9:827–833CrossRefPubMed
2.
Zurück zum Zitat Alter P, Watz H, Kahnert K et al (2018) Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling. Respir Med 137:14–22CrossRefPubMed Alter P, Watz H, Kahnert K et al (2018) Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling. Respir Med 137:14–22CrossRefPubMed
3.
Zurück zum Zitat Barisione G, Pellegrino R (2015) Body plethysmography is helpful for COPD diagnosis, determination of severity, phenotyping, and response to therapy. COPD 12(6):591–594CrossRefPubMed Barisione G, Pellegrino R (2015) Body plethysmography is helpful for COPD diagnosis, determination of severity, phenotyping, and response to therapy. COPD 12(6):591–594CrossRefPubMed
4.
Zurück zum Zitat Bates DV, Woolf CR, Paul GI (1962) A report on the first two stages of the co-ordinated study of chronic bronchitis in the Department of Veterans Affairs, Canada. Med Serv J Can 18:211–303PubMed Bates DV, Woolf CR, Paul GI (1962) A report on the first two stages of the co-ordinated study of chronic bronchitis in the Department of Veterans Affairs, Canada. Med Serv J Can 18:211–303PubMed
5.
Zurück zum Zitat Bertens LC et al (2013) Use of expert panels to define the reference standard in diagnostic research: A systematic review of published methods and reporting. PLoS Med 10:e1001531CrossRefPubMedPubMedCentral Bertens LC et al (2013) Use of expert panels to define the reference standard in diagnostic research: A systematic review of published methods and reporting. PLoS Med 10:e1001531CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Boudestein LC, Rutten FH, Cramer MJ et al (2009) The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail 11:1182–1188CrossRefPubMed Boudestein LC, Rutten FH, Cramer MJ et al (2009) The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail 11:1182–1188CrossRefPubMed
7.
Zurück zum Zitat Brenner S, Güder G, Berliner D et al (2013) Airway obstruction in systolic heart failure—COPD or congestion? Int J Cardiol 168(3):1910–1916CrossRefPubMed Brenner S, Güder G, Berliner D et al (2013) Airway obstruction in systolic heart failure—COPD or congestion? Int J Cardiol 168(3):1910–1916CrossRefPubMed
8.
Zurück zum Zitat Campbell RT, Mcmurray JJ (2014) Comorbidities and differential diagnosis in heart failure with preserved ejection fraction. Heart Fail Clin 10:481–501CrossRefPubMed Campbell RT, Mcmurray JJ (2014) Comorbidities and differential diagnosis in heart failure with preserved ejection fraction. Heart Fail Clin 10:481–501CrossRefPubMed
9.
Zurück zum Zitat Du Q, Sun Y, Ding N et al (2014) Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: A meta-analysis of observational studies. PLoS ONE 9:e113048CrossRefPubMedPubMedCentral Du Q, Sun Y, Ding N et al (2014) Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: A meta-analysis of observational studies. PLoS ONE 9:e113048CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Enright P (2015) Body plethysmography is not helpful for COPD diagnosis, determination of severity, phenotyping, nor response to therapy. COPD 12(6):595–597CrossRefPubMed Enright P (2015) Body plethysmography is not helpful for COPD diagnosis, determination of severity, phenotyping, nor response to therapy. COPD 12(6):595–597CrossRefPubMed
11.
Zurück zum Zitat Faggiano P (1994) Abnormalities of pulmonary function in congestive heart failure. Int J Cardiol 44:1–8CrossRefPubMed Faggiano P (1994) Abnormalities of pulmonary function in congestive heart failure. Int J Cardiol 44:1–8CrossRefPubMed
12.
Zurück zum Zitat Ferrari R et al (2015) Heart failure with preserved ejection fraction: Uncertainties and dilemmas. Eur J Heart Fail 17:665–671CrossRefPubMed Ferrari R et al (2015) Heart failure with preserved ejection fraction: Uncertainties and dilemmas. Eur J Heart Fail 17:665–671CrossRefPubMed
13.
Zurück zum Zitat Fletcher CM (1960) Standardised questionnaire on respiratory symptoms: A statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ 2:1662 Fletcher CM (1960) Standardised questionnaire on respiratory symptoms: A statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ 2:1662
15.
Zurück zum Zitat Galie N, Humbert M, Vachiery JL et al (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67–119CrossRefPubMed Galie N, Humbert M, Vachiery JL et al (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67–119CrossRefPubMed
16.
Zurück zum Zitat Global Initiative for Chronic Obstructive Lung Disease (2019) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2019 Report. www.goldcopd.org. Accessed: 23 March 2019 Global Initiative for Chronic Obstructive Lung Disease (2019) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2019 Report. www.​goldcopd.​org. Accessed: 23 March 2019
17.
Zurück zum Zitat Greenberger PA et al (1991) A prospective evaluation of elevated serum theophylline concentrations to determine if high concentrations are predictable. Am J Med 91:67–73CrossRefPubMed Greenberger PA et al (1991) A prospective evaluation of elevated serum theophylline concentrations to determine if high concentrations are predictable. Am J Med 91:67–73CrossRefPubMed
18.
Zurück zum Zitat Güder G, Brenner S, Angermann CE et al (2012) GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res 13(1):13CrossRefPubMedPubMedCentral Güder G, Brenner S, Angermann CE et al (2012) GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res 13(1):13CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Güder G, Brenner S, Stork S et al (2014) Chronic obstructive pulmonary disease in heart failure: Accurate diagnosis and treatment. Eur J Heart Fail 16(12):1273–1282CrossRefPubMed Güder G, Brenner S, Stork S et al (2014) Chronic obstructive pulmonary disease in heart failure: Accurate diagnosis and treatment. Eur J Heart Fail 16(12):1273–1282CrossRefPubMed
20.
Zurück zum Zitat Güder G, Rutten FH (2014) Comorbidity of heart failure and chronic obstructive pulmonary disease: More than coincidence. Curr Heart Fail Rep 11(3):337–346CrossRefPubMed Güder G, Rutten FH (2014) Comorbidity of heart failure and chronic obstructive pulmonary disease: More than coincidence. Curr Heart Fail Rep 11(3):337–346CrossRefPubMed
21.
Zurück zum Zitat Güder G, Rutten FH, Brenner S et al (2012) The impact of heart failure on the classification of COPD severity. J Card Fail 18(8):637–644CrossRefPubMed Güder G, Rutten FH, Brenner S et al (2012) The impact of heart failure on the classification of COPD severity. J Card Fail 18(8):637–644CrossRefPubMed
22.
Zurück zum Zitat Güder G et al (2015) Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Eur J Heart Fail 17(4):442–452CrossRefPubMed Güder G et al (2015) Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Eur J Heart Fail 17(4):442–452CrossRefPubMed
23.
Zurück zum Zitat Guo X, Nie H, Chen Q et al (2018) The role of plasma N‑terminal brain natriuretic pro-peptide in diagnosing elderly patients with acute exacerbation of COPD concurrent with left heart failure. Int J Chron Obstruct Pulmon Dis 13:2931–2940CrossRefPubMedPubMedCentral Guo X, Nie H, Chen Q et al (2018) The role of plasma N‑terminal brain natriuretic pro-peptide in diagnosing elderly patients with acute exacerbation of COPD concurrent with left heart failure. Int J Chron Obstruct Pulmon Dis 13:2931–2940CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Hawkins NM (2018) Chronic obstructive pulmonary disease and heart failure in Europe-further evidence of the need for integrated care. Eur J Heart Fail 20:111–113CrossRefPubMed Hawkins NM (2018) Chronic obstructive pulmonary disease and heart failure in Europe-further evidence of the need for integrated care. Eur J Heart Fail 20:111–113CrossRefPubMed
25.
Zurück zum Zitat Hawkins NM, Petrie MC, Jhund PS et al (2009) Heart failure and chronic obstructive pulmonary disease: Diagnostic pitfalls and epidemiology. Eur J Heart Fail 11:130–139CrossRefPubMedPubMedCentral Hawkins NM, Petrie MC, Jhund PS et al (2009) Heart failure and chronic obstructive pulmonary disease: Diagnostic pitfalls and epidemiology. Eur J Heart Fail 11:130–139CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Hawkins NM, Virani S, Ceconi C (2013) Heart failure and chronic obstructive pulmonary disease: The challenges facing physicians and health services. Eur Heart J 34:2795–2807CrossRefPubMed Hawkins NM, Virani S, Ceconi C (2013) Heart failure and chronic obstructive pulmonary disease: The challenges facing physicians and health services. Eur Heart J 34:2795–2807CrossRefPubMed
27.
Zurück zum Zitat Henderson Y (1923) Volume changes of the heart. Physiol Rev 3:165–208CrossRef Henderson Y (1923) Volume changes of the heart. Physiol Rev 3:165–208CrossRef
28.
Zurück zum Zitat Hohlfeld JM, Vogel-Claussen J, Biller H et al (2018) Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): A double-blind, randomised, crossover, placebo-controlled, single-centre trial. Lancet Respir Med 6:368–378CrossRefPubMed Hohlfeld JM, Vogel-Claussen J, Biller H et al (2018) Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): A double-blind, randomised, crossover, placebo-controlled, single-centre trial. Lancet Respir Med 6:368–378CrossRefPubMed
29.
Zurück zum Zitat Iversen KK et al (2008) Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med 264:361–369CrossRefPubMed Iversen KK et al (2008) Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med 264:361–369CrossRefPubMed
30.
Zurück zum Zitat Jabbour A, Macdonald PS, Keogh AM et al (2010) Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: A randomized crossover trial. J Am Coll Cardiol 55:1780–1787CrossRefPubMed Jabbour A, Macdonald PS, Keogh AM et al (2010) Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: A randomized crossover trial. J Am Coll Cardiol 55:1780–1787CrossRefPubMed
31.
Zurück zum Zitat Johannessen A et al (2006) Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 173:1316–1325CrossRefPubMed Johannessen A et al (2006) Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 173:1316–1325CrossRefPubMed
32.
Zurück zum Zitat Jones PW, Harding G, Berry P et al (2009) Development and first validation of the COPD assessment test. Eur Respir J 34:648–654CrossRef Jones PW, Harding G, Berry P et al (2009) Development and first validation of the COPD assessment test. Eur Respir J 34:648–654CrossRef
33.
Zurück zum Zitat Jorge S, Becquemin MH, Delerme S et al (2007) Cardiac asthma in elderly patients: Incidence, clinical presentation and outcome. BMC Cardiovasc Disord 7:16CrossRefPubMedPubMedCentral Jorge S, Becquemin MH, Delerme S et al (2007) Cardiac asthma in elderly patients: Incidence, clinical presentation and outcome. BMC Cardiovasc Disord 7:16CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Kahnert K, Alter P, Young D et al (2018) The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med 134:79–85CrossRefPubMed Kahnert K, Alter P, Young D et al (2018) The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med 134:79–85CrossRefPubMed
37.
Zurück zum Zitat Light RW, George RB (1983) Serial pulmonary function in patients with acute heart failure. Arch Intern Med 143:429–433CrossRefPubMed Light RW, George RB (1983) Serial pulmonary function in patients with acute heart failure. Arch Intern Med 143:429–433CrossRefPubMed
38.
Zurück zum Zitat Manning HL, Schwartzstein RM (1995) Pathophysiology of dyspnea. N Engl J Med 333:1547–1553CrossRefPubMed Manning HL, Schwartzstein RM (1995) Pathophysiology of dyspnea. N Engl J Med 333:1547–1553CrossRefPubMed
39.
Zurück zum Zitat Marks GB (2012) Are reference equations for spirometry an appropriate criterion for diagnosing disease and predicting prognosis? Thorax 67:85–87CrossRefPubMed Marks GB (2012) Are reference equations for spirometry an appropriate criterion for diagnosing disease and predicting prognosis? Thorax 67:85–87CrossRefPubMed
40.
Zurück zum Zitat Minasian AG et al (2013) Bronchodilator responsiveness in patients with chronic heart failure. Heart Lung 42(3):208–214CrossRefPubMed Minasian AG et al (2013) Bronchodilator responsiveness in patients with chronic heart failure. Heart Lung 42(3):208–214CrossRefPubMed
41.
Zurück zum Zitat Mulrow CD, Lucey CR, Farnett LE (1993) Discriminating causes of dyspnea through clinical examination. J Gen Intern Med 8:383–392CrossRefPubMed Mulrow CD, Lucey CR, Farnett LE (1993) Discriminating causes of dyspnea through clinical examination. J Gen Intern Med 8:383–392CrossRefPubMed
42.
Zurück zum Zitat Nagueh SF, Middleton KJ, Kopelen HA et al (1997) Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533CrossRefPubMed Nagueh SF, Middleton KJ, Kopelen HA et al (1997) Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533CrossRefPubMed
43.
Zurück zum Zitat Olschewski H, Behr J, Bremer H et al (2018) Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol 272S:63–68CrossRefPubMed Olschewski H, Behr J, Bremer H et al (2018) Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol 272S:63–68CrossRefPubMed
44.
Zurück zum Zitat Palazzini M et al (2018) Pulmonary hypertension due to left heart disease: Analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes. Eur J Heart Fail 20:248–255CrossRefPubMed Palazzini M et al (2018) Pulmonary hypertension due to left heart disease: Analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes. Eur J Heart Fail 20:248–255CrossRefPubMed
45.
Zurück zum Zitat Paulus WJ, Tschöpe C, Sanderson JE et al (2007) How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28(20):2539–2550CrossRefPubMed Paulus WJ, Tschöpe C, Sanderson JE et al (2007) How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28(20):2539–2550CrossRefPubMed
46.
Zurück zum Zitat Petersen H, Sood A, Meek PM et al (2014) Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use. Chest 145:695–703CrossRefPubMed Petersen H, Sood A, Meek PM et al (2014) Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use. Chest 145:695–703CrossRefPubMed
47.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975CrossRefPubMed Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975CrossRefPubMed
48.
49.
Zurück zum Zitat Rosenkranz S, Gibbs JS, Wachter R et al (2016) Left ventricular heart failure and pulmonary hypertension. Eur Heart J 37:942–954CrossRefPubMed Rosenkranz S, Gibbs JS, Wachter R et al (2016) Left ventricular heart failure and pulmonary hypertension. Eur Heart J 37:942–954CrossRefPubMed
50.
Zurück zum Zitat Rosenkranz S et al (2018) Pulmonary hypertension associated with left heart disease: Updated recommendations of the Cologne Consensus Conference 2018. Int J Cardiol 272S:53–62CrossRefPubMed Rosenkranz S et al (2018) Pulmonary hypertension associated with left heart disease: Updated recommendations of the Cologne Consensus Conference 2018. Int J Cardiol 272S:53–62CrossRefPubMed
51.
Zurück zum Zitat Rutten FH, Cramer MJ, Grobbee DE et al (2005) Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26:1887–1894CrossRefPubMed Rutten FH, Cramer MJ, Grobbee DE et al (2005) Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26:1887–1894CrossRefPubMed
52.
Zurück zum Zitat Rutten FH, Cramer MJ, Lammers JW et al (2006) Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail 8:706–711CrossRefPubMed Rutten FH, Cramer MJ, Lammers JW et al (2006) Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail 8:706–711CrossRefPubMed
53.
Zurück zum Zitat Rutten FH, Groenwold RH, Sachs AP et al (2013) Beta-blockers and all-cause mortality in adults with episodes of acute bronchitis: An observational study. PLoS ONE 8:e67122CrossRefPubMedPubMedCentral Rutten FH, Groenwold RH, Sachs AP et al (2013) Beta-blockers and all-cause mortality in adults with episodes of acute bronchitis: An observational study. PLoS ONE 8:e67122CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Salpeter SR (2009) Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events? A synthesis of the available evidence. Drugs 69:2025–2033CrossRefPubMed Salpeter SR (2009) Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events? A synthesis of the available evidence. Drugs 69:2025–2033CrossRefPubMed
55.
Zurück zum Zitat Stone IS, Barnes NC, James WY et al (2016) Lung deflation and cardiovascular structure and function in chronic obstructive pulmonary disease. A randomized controlled trial. Am J Respir Crit Care Med 193:717–726CrossRefPubMedPubMedCentral Stone IS, Barnes NC, James WY et al (2016) Lung deflation and cardiovascular structure and function in chronic obstructive pulmonary disease. A randomized controlled trial. Am J Respir Crit Care Med 193:717–726CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat Swanney MP, Ruppel G, Enright PL et al (2008) Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 63:1046–1051CrossRefPubMed Swanney MP, Ruppel G, Enright PL et al (2008) Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 63:1046–1051CrossRefPubMed
57.
Zurück zum Zitat Tanabe T, Rozycki HJ, Kanoh S et al (2013) Cardiac asthma: New insights into an old disease. Expert Rev Respir Med 6:705–714CrossRef Tanabe T, Rozycki HJ, Kanoh S et al (2013) Cardiac asthma: New insights into an old disease. Expert Rev Respir Med 6:705–714CrossRef
58.
Zurück zum Zitat Vasan RS, Levy D (2000) Defining diastolic heart failure: A call for standardized diagnostic criteria. Circulation 101:2118–2121CrossRefPubMed Vasan RS, Levy D (2000) Defining diastolic heart failure: A call for standardized diagnostic criteria. Circulation 101:2118–2121CrossRefPubMed
59.
Zurück zum Zitat Vestbo J et al (2016) Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): A double-blind randomised controlled trial. Lancet 387:1817–1826CrossRefPubMed Vestbo J et al (2016) Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): A double-blind randomised controlled trial. Lancet 387:1817–1826CrossRefPubMed
60.
Zurück zum Zitat Vogel-Claussen J, Schönfeld CO, Kaireit TF et al (2019) Effect of indacaterol/glycopyrronium on pulmonary perfusion and ventilation in hyperinflated COPD patients (CLAIM): A double-blind, randomised, crossover trial. Am J Respir Crit Care Med 199(9):1086–1096CrossRefPubMed Vogel-Claussen J, Schönfeld CO, Kaireit TF et al (2019) Effect of indacaterol/glycopyrronium on pulmonary perfusion and ventilation in hyperinflated COPD patients (CLAIM): A double-blind, randomised, crossover trial. Am J Respir Crit Care Med 199(9):1086–1096CrossRefPubMed
61.
Zurück zum Zitat West RL, Hernandez AF, O’connor CM et al (2010) A review of dyspnea in acute heart failure syndromes. Am Heart J 160:209–214CrossRefPubMed West RL, Hernandez AF, O’connor CM et al (2010) A review of dyspnea in acute heart failure syndromes. Am Heart J 160:209–214CrossRefPubMed
62.
Zurück zum Zitat Witte KK, Clark AL (2005) Beta-blockers and inspiratory pulmonary function in chronic heart failure. J Card Fail 11:112–116CrossRefPubMed Witte KK, Clark AL (2005) Beta-blockers and inspiratory pulmonary function in chronic heart failure. J Card Fail 11:112–116CrossRefPubMed
Metadaten
Titel
COPD and heart failure: differential diagnosis and comorbidity
verfasst von
G. Güder, MD, PhD
S. Störk
Publikationsdatum
20.05.2019
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 6/2019
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-019-4814-7

Weitere Artikel der Ausgabe 6/2019

Herz 6/2019 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.